Literature DB >> 9141655

Molecular mechanisms of azole resistance in fungi.

T Joseph-Horne1, D W Hollomon.   

Abstract

This paper reviews the current status of our understanding of azole antifungal resistance mechanisms at the molecular level and explores their implications. Extensive biochemical studies have highlighted a significant diversity in mechanisms conferring resistance to azoles, which include alterations in sterol biosynthesis, target site, uptake and efflux. In stark contrast, few examples document the molecular basis of azole resistance. Those that do refer almost exclusively to mechanisms in laboratory mutants, with the exception of the role of multi-drug resistance proteins in clinical isolates of Candida albicans. It is clear that the technologies required to examine and define azole resistance mechanisms at the molecular level exist, but research appears distinctly lacking in this most important area.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141655     DOI: 10.1111/j.1574-6968.1997.tb10321.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  33 in total

Review 1.  Mechanisms of fungal resistance: an overview.

Authors:  Maher M Balkis; Steven D Leidich; Pranab K Mukherjee; Mahmoud A Ghannoum
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

3.  Genetic analysis of azole resistance by transposon mutagenesis in Saccharomyces cerevisiae.

Authors:  D P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.

Authors:  P Marichal; J Gorrens; L Laurijssens; K Vermuyten; C Van Hove; L Le Jeune; P Verhasselt; D Sanglard; M Borgers; F C Ramaekers; F Odds; H Vanden Bossche
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae.

Authors:  D P Kontoyiannis; N Sagar; K D Hirschi
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 6.  Topical antimicrobials for burn wound infections.

Authors:  T Dai; Y Y Huang; S K Sharma; J T Hashmi; D B Kurup; M R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2010-06

7.  Evolution of cross-resistance to medical triazoles in Aspergillus fumigatus through selection pressure of environmental fungicides.

Authors:  Jianhua Zhang; Joost van den Heuvel; Alfons J M Debets; Paul E Verweij; Willem J G Melchers; Bas J Zwaan; Sijmen E Schoustra
Journal:  Proc Biol Sci       Date:  2017-09-27       Impact factor: 5.349

8.  Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species.

Authors:  E Mellado; T M Diaz-Guerra; M Cuenca-Estrella; J L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

9.  Cyclic AMP and fluconazole resistance in Saccharomyces cerevisiae.

Authors:  D P Kontoyiannis; S Rupp
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

10.  Candida albicans flu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentration and fungicidal activity.

Authors:  Rui Li; Rohitashw Kumar; Swetha Tati; Sumant Puri; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.